Cellatoz Therapeutics, Inc.
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cellatozrx.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Cellatoz Therapeutics, Inc
- Target Recruit Count
- 9
- Registration Number
- NCT05947578
- Locations
- π°π·
Samsung Medical center, Seoul, Gangnam-gu, Korea, Republic of
News
No news found